RBX-I'd like your opinion on this note GK sent me December 2014 in a discussion on Phenoxodial. I'm not attempting to disparage NOX66, I hope it works and cures every single patient. As a KZA holder, I now wonder if GK was exaggerating the potency of Cantrixil.
Frankie
Phenoxodiol is to TRXE-002 (the active ingredient in Cantrixil) what an electric car is to a F1 racing car. The IC50 frange or phenoxodiol is 2000-5000 nM. The range for TRXE-002 is 10-100 nM.
Phenoxodiol has no effect on cancer stem cells; TRXE-002 is highly potent against cancer stem cells.
Phenoxodiol is a potent chemo-sensitiser; TRXE-002 has no chemo-sensitising ability.
Phenoxodiol is an interesting drug; TRXE-002 is a potential breakthrough drug.
Novogen and MEIP are completely divorced. They got the children; Novogen got its freedom to operate.
Regards
Dr Graham Kelly
Chairman and Chief Executive Officer
Novogen Ltd
- Forums
- ASX - By Stock
- NOX
- ESMO Presentation
NOX
noxopharm limited
Add to My Watchlist
3.61%
!
8.0¢
ESMO Presentation, page-6
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
